Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review

被引：0
|
作者：
Vincent Dochez
Hélène Caillon
Edouard Vaucel
Jérôme Dimet
Norbert Winer
Guillaume Ducarme
机构：
[1] CHU de Nantes,Service de Gynécologie
[2] CHU de Nantes,Obstétrique
[3] Centre Hospitalier Départemental Vendée,Service de Biochimie
[4] Centre Hospitalier Départemental Vendée,Centre de recherche clinique
来源：
Journal of Ovarian Research | / 12卷
关键词：
HE4; CA125; ROMA; RMI; Ovarian cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Ovarian cancer is the 5th leading cause of death for women with cancer worldwide. In more than 70% of cases, it is only diagnosed at an advanced stage. Our study aims to give an update on the biological markers for diagnosing ovarian cancer, specifically HE4, CA 125, RMI and ROMA algorithms.
引用
收藏
相关论文
共 50 条
  • [1] Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
    Dochez, Vincent
    Caillon, Helene
    Vaucel, Edouard
    Dimet, Jerome
    Winer, Norbert
    Ducarme, Guillaume
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (1)
  • [2] Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis
    Zhang, Lei
    Chen, Ying
    Wang, Ke
    CURRENT PROBLEMS IN CANCER, 2019, 43 (02) : 135 - 144
  • [3] APPLICATION VALUE OF HE4, CA125 AND ROMA IN DIAGNOSIS OF THE OVARIAN CANCER
    Sun, Wenchao
    Wang, Jinfang
    Liu, Lubin
    ACTA MEDICA MEDITERRANEA, 2020, 36 (03): : 1765 - 1769
  • [4] Diagnostic performances of HE4, CA125, RMI and ROMA for the detection of ovarian cancer in presumed benign ovarian tumours
    Dochez, V
    Randet, M.
    Renaudeau, C.
    Dimet, J.
    Le Thuaut, A.
    Caillon, H.
    Vaucel, E.
    Ducarme, G.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 124 : 77 - 77
  • [5] Early diagonosis of ovarian cancer: serum HE4, CA125 and ROMA model
    Wang, Haixia
    Liu, Pingping
    Xu, Hai
    Dai, Hongmei
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (12): : 14141 - 14148
  • [6] Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4
    Ghose, Aruni
    McCann, Lucy
    Makker, Shania
    Mukherjee, Uma
    Gullapalli, Sri Vidya Niharika
    Erekkath, Jayaraj
    Shih, Stephanie
    Mahajan, Ishika
    Sanchez, Elisabet
    Uccello, Mario
    Moschetta, Michele
    Adeleke, Sola
    Boussios, Stergios
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [7] HE4 AND CA125 IN OVARIAN CANCER PATIENTS
    Kotowicz, B.
    Fuksiewicz, M.
    Kowalska, M.
    Sobiczewski, P.
    Skrzypczak, M.
    Spiewankiewicz, B.
    Kaminska, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [8] HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer
    Ortiz-Munoz, Blanca
    Aznar-Oroval, Eduardo
    Garcia Garcia, Ana
    Covisa Peris, Amparo
    Perez Ballestero, Pilar
    Sanchez Yepes, Marina
    Garcia Lozano, Tomas
    Illueca Ballester, Carmen
    Garcia Garcia, Enrique
    TUMOR BIOLOGY, 2014, 35 (07) : 7249 - 7258
  • [9] A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses
    Anton, Cristina
    Carvalho, Filomena Marino
    Oliveira, Elci Isabel
    Rosa Maciel, Gustavo Arantes
    Baracat, Edmund Chada
    Carvalho, Jesus Paula
    CLINICS, 2012, 67 (05) : 437 - 441
  • [10] HE4 and CA125 in ovarian malignancy
    Perovic, M.
    CLINICA CHIMICA ACTA, 2022, 530 : S62 - S62
12345